Bob Block

Bob Block, an acute care clinical pharmacist, joins the conversation to unravel the multifaceted story of ivermectin. He traces its journey from a wonder drug in Japan to its controversial role during the COVID-19 pandemic. Bob simplifies the drug's mechanisms and discusses why sourcing it from feed stores is risky. They explore promising research on its anticancer potential while cautioning about limited human data. Listeners gain insight into the impact of misinformation on public perception and the need for evidence-based medicine.